SCHEMBL434056

SCHEMBL434056

CCCCN(CCCC)CCCOc1ccc(C(C)=O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.67
THRA P10827 1/20 0.66
THRB P10828 1/20 0.66
GAA P10253 2/20 0.65
BCHE P06276 5/20 0.61
ACHE P22303 3/20 0.56
MAOB P27338 2/20 0.55
TP53 P04637 1/20 0.54
TSHR P16473 1/20 0.54
LMNA P02545 1/20 0.54
CYP1A2 P05177 1/20 0.54
CHRM2 P08172 1/20 0.54
CYP3A4 P08684 1/20 0.54
HTR1A P08908 1/20 0.54
CYP2D6 P10635 1/20 0.54
DRD3 P35462 1/20 0.54
SCN1A P35498 1/20 0.54
SLC6A3 Q01959 1/20 0.54
KCNH2 Q12809 1/20 0.54
SCN2A Q99250 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL491797 0.89 L3MBTL1 (0.69) L3MBTL1GAABCHEACHEMAOB
SCHEMBL1092185 0.88 L3MBTL1 (0.85) L3MBTL1GAATP53TSHRLMNA
SCHEMBL2472164 0.88 TP53 (0.71) THRATHRBBCHEACHETP53
SCHEMBL321662 0.86 THRA (0.64) THRATHRBGAABCHEACHE
Hydrochloric Acid SCHEMBL3853408 0.86 TP53 (0.69) THRATHRBBCHEACHETP53
SCHEMBL15537107 0.86 THRA (0.64) THRATHRBGAABCHEACHE
Hydrochloric Acid SCHEMBL15049975 0.86 TP53 (0.69) THRATHRBBCHEACHETP53
SCHEMBL1470028 0.85 L3MBTL1 (0.85) L3MBTL1THRATHRBGAATP53
SCHEMBL2472562 0.85 MAPT (0.66) THRATHRBGAABCHEACHE
Hydrochloric Acid SCHEMBL284154 0.85 THRA (0.63) THRATHRBGAABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512097-B2 Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives LEK PHARMACEUTICALS D.D. (SI) 2016-12-06 US disclosed
US-9512097-B2 Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives LEK PHARMACEUTICALS D.D. (SI) 2016-12-06 US disclosed
US-8748636-B2 Process for preparing benzofuran derivatives substituted at position 5 SANOFI (FR) 2014-06-10 US disclosed
US-8674121-B2 Process for the production of benzofurans SANOFI (FR) 2014-03-18 US disclosed
EP-2435398-B1 PROCESS FOR THE PRODUCTION OF BENZOFURANS SANOFI SA (FR) 2014-01-22 EP disclosed
US-20130317100-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK PHARMACEUTICALS D.D. (SI) 2013-11-28 US disclosed
EP-2638024-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK Pharmaceuticals d.d. (SI) 2013-09-18 EP disclosed
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-06-27 US disclosed
EP-2595977-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2013-05-29 EP disclosed
WO-2012062918-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK PHARMACEUTICALS D.D. (SI) 2012-05-18 WO disclosed
WO-2012062918-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK PHARMACEUTICALS D.D. (SI) 2012-05-18 WO disclosed
EP-2452938-A1 Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives LEK Pharmaceuticals d.d. (SI) 2012-05-16 EP disclosed
EP-2452938-A1 Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives LEK Pharmaceuticals d.d. (SI) 2012-05-16 EP disclosed
US-20120065411-A1 PROCESS FOR THE PRODUCTION OF BENZOFURANS SANOFI (FR) 2012-03-15 US disclosed
WO-2012010802-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 SANOFI (FR) 2012-01-26 WO disclosed
US-20110178314-A1 PROCESS FOR PREPARING 2-ALKYL-3-AROYL-5-NITRO-BENZOFURANS LONZA AG (CH) 2011-07-21 US disclosed
EP-2344467-A1 PROCESS FOR PREPARING 2-ALKYL-3-AROYL-5-NITRO-BENZOFURANS Lonza Ltd. (CH) 2011-07-20 EP disclosed
WO-2010136500-A1 PROCESS FOR THE PRODUCTION OF BENZOFURANS SANOFI-AVENTIS (FR) 2010-12-02 WO disclosed
EP-2246341-A1 Process for preparing 2-Alkyl-3-aroyl-5-nitro-benzofurans Lonza Ltd. (CH) 2010-11-03 EP disclosed
WO-2010040261-A1 PROCESS FOR PREPARING 2-ALKYL-3-AROYL-5-NITRO-BENZOFURANS LONZA LTD (CH) 2010-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165674-A1 PROCESS FOR PREPARING BENZOFURAN DERIVATIVES SUBSTITUTED AT POSITION 5 DHPS, SDHA, CYP2F1 L3MBTL1 4375/4885THRA 3592/4885THRB 3390/4885
US-20130317100-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES CYP3A5, CYP4F3, CYP3A4 L3MBTL1 4354/4885THRA 3854/4885THRB 3183/4885
US-20120065411-A1 PROCESS FOR THE PRODUCTION OF BENZOFURANS CYP2F1, CYP2B6, CYP4F2 L3MBTL1 3348/4885THRA 3015/4885THRB 3589/4885
US-20110178314-A1 PROCESS FOR PREPARING 2-ALKYL-3-AROYL-5-NITRO-BENZOFURANS NR4A3, CBR3, NR4A1 L3MBTL1 3448/4885THRA 1857/4885THRB 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.